CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022

/PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management plans to report its third quarter 2022 financial results on...

Related Keywords

,Biopharma Corp ,Pharma Investor Contacts ,Cti Biopharma Corp ,